John Romano
Analyst · BMO Capital Market
Thanks, John. So the first half of 2024 has already demonstrated a reversal of some of the trends from the prior two years, and we anticipate that recovery to continue. On a year-to-date basis through Q2, our TiO2 volumes were up approximately 17%, and our Zircon volumes increased approximately 20% compared to the prior year. Although ,we are not yet back to normalized volume levels on either TiO2 or Zircon, the improvement this year is a demonstration that 2023 was indeed a trough year for volume demand. In addition to the recovery, we have also seen the launch of several anti-dumping investigations. Most notably, the EU announced a provisional duty last month on Chinese imports, while Brazil and India each have investigations underway. We believe these efforts will be a benefit in the medium and long term, and we will continue to monitor the short-term impacts from these announcements. On the operational side this year, we've been ramping up our assets to meet the increased customer demand over 2023. As we were ramping up, we experienced some operational challenges across our sites, which caused Q2 operating rates to come in lower than what we had targeted, and this led to higher costs in Q2 and higher anticipated costs in Q3. Due to the breadth of our geographic footprint, we were able to continue to meet customer demand as we resolved these issues. We have previously indicated that lower utilization rates impacted our business by $25 million to $35 million per quarter, and our startup challenges in Q2 resulted in a similar impact. To put that into context, we incurred roughly half of the impact in the second quarter and expect the remaining half to impact the third quarter, which is included in our outlook. These short-term challenges have now been resolved, and our average utilization rates for July were in the 80% range. We expect to continue running at this rate through the second half of the year, which will result in lower cost and a step up in our earnings momentum in Q4. As we ramp up, we're continuing to see the benefits of the technology we've deployed at our sites to reduce costs and improve efficiencies. As we mentioned in the last two quarters, we're investing $395 million in capital expenditures primarily in the mining side of the business in South Africa to sustain vertical integration. As a reminder, in 2024, we expect to invest a total of approximately $130 million in our two South African mining projects, the Fairbreeze Expansion and the Namakwa East OFS. These investments will ensure we maintain our $300 to $400 per metric ton advantage for feedstock sourced internally. From a growth perspective, our R&D efforts remain focused on product and process innovations to enhance our profitability and we're continuing to explore opportunities in rare earth space. Moving to slide 12, I'll now review our outlook. While the macro backdrop for the second half of 2024 is expected to be less robust than previously anticipated, Tronox has realized and expects to continue to realize considerable growth compared to 2023. For the third quarter, we expect TiO2 volumes to decline and in line with seasonal norms by approximately 2% to 4% compared the second quarter. This represents an increase in the high teens range compared to the third quarter of 2023. Regarding Zircon, we anticipate stable volumes in the third quarter, which would represent an increase of approximately 160% compared to the trough levels we realized in the third quarter of last year. We anticipate TiO2 prices to increase marginally compared to Q2 and we expect TiO2 and Zircon pricing to remain relatively stable. On our cost, the higher cost pigment tons manufactured in the second quarter will impact our profitability as these tons are sold in the third quarter and this has been factored into the range. Additionally, based on current exchange rates, we expect FX to be a slight headwind in Q3. As a result of these factors and assumptions, we expect third quarter adjusted EBITDA to be between $145 million and $165 million and our adjusted EBITDA margin to be in the high teens. As previously referenced, our average utilization rates are now running at 80% range, and we expect that to continue through the second half of the year. This will result in improvement in pigment manufacturing costs and a step up in earnings momentum sequentially in the fourth quarter. On cash, our expectations for 2024 remain unchanged and are as follows. Our capital expenditures are expected to be approximately $395 million for the year. Our net cash taxes are expected to be less than $10 million, as the significant capital expenditures in South Africa are deductible. Our net cash interest is expected to be $140 million, and we're expecting working capital to be a tailwind. The magnitude of the cash inflow will depend on the market trends in the second half. Turning to slide 13, I'd like to briefly remind investors of our capital allocation priorities before turning over to questions. Our capital allocation strategy is not changed. We continue to prioritize investments in the business that are essential for advancing our strategy and maximizing value for a vertically integrated business. We also remain focused on strengthening our liquidity and resuming debt pay down as the market recovers, and our dividend remains a priority. And finally, we'll continue to assess strategic high growth opportunities as they emerge, including the rare earth space, which is an active focus for us at the moment. We'll provide more updates on this as developments happen with these projects. That will conclude the prepared remarks and we'll now move to the Q&A portion of the call, so I will hand the call back over to the operator to facilitate that. Operator?